Michael Kragh
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 31
- HER2/EGFR in Cancer Research 18
- Colorectal Cancer Treatments and Studies 8
-
- Monoclonal and Polyclonal Antibodies Research 11
- Co-authors
- Mikkel Wandahl Pedersen (17 shared papers)Helle Jane Jacobsen (8 shared papers)Klaus Koefoed (8 shared papers)Ivan David Horak (20 shared papers)Johan Lantto (14 shared papers)Paul E.G. Kristjansen (7 shared papers)John Sørensen Haurum (2 shared papers)Adam Hey (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (7 papers)Clinical Cancer Research (5 papers)Annals of Oncology (3 papers)Neoplasia (3 papers)Oncology Reports (2 papers)
- Partner nations
- DenmarkUnited StatesSpain
In The Last Decade
Michael Kragh
46 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 92
- Oncology 1.1k
- Cancer Research 364
- Radiology, Nuclear Medicine and Imaging 515
- Immunology 330
- Hepatology 96
Countries citing papers authored by Michael Kragh
This map shows the geographic impact of Michael Kragh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kragh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kragh more than expected).
Fields of papers citing papers by Michael Kragh
This network shows the impact of papers produced by Michael Kragh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kragh. The network helps show where Michael Kragh may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Kragh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 396 | |
| 2 | 2010 | 189 | |
| 3 | 2018 | 113 | |
| 4 | 2008 | 88 | |
| 5 | 2011 | 81 | |
| 6 | 2015 | 79 | |
| 7 | 2019 | 72 | |
| 8 | 2020 | 68 | |
| 9 | 2015 | 67 | |
| 10 | 2007 | 64 | |
| 11 | 2016 | 60 | |
| 12 | 2013 | 59 | |
| 13 | Non-anti-coagulant heparin inhibits metastasis but not primary tumor growth. | 2005 | 48 |
| 14 | 2015 | 46 | |
| 15 | 2017 | 44 | |
| 16 | 2019 | 43 | |
| 17 | 2017 | 41 | |
| 18 | 2016 | 36 | |
| 19 | 2005 | 35 | |
| 20 | 2011 | 35 |
About Michael Kragh
Michael Kragh is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 46 papers that have together received 2.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (8 papers), Angiogenesis and VEGF in Cancer (6 papers), Glycosylation and Glycoproteins Research (4 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (364 citations), Radiology, Nuclear Medicine and Imaging (515 citations), Immunology (330 citations) and Hepatology (96 citations). Michael Kragh has collaborated with scholars based in Denmark, United States and Spain. Frequent co-authors include Mikkel Wandahl Pedersen, Helle Jane Jacobsen, Klaus Koefoed, Ivan David Horak, Johan Lantto, Paul E.G. Kristjansen, John Sørensen Haurum, Adam Hey, Thomas Tuxen Poulsen and Charles Pyke. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Annals of Oncology, Neoplasia and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.